Terms: = Testicular cancer AND AFP, AFPD, FETA, HPAFP AND Diagnosis
223 results:
1. Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation.
Ricci C; Ambrosi F; Grillini A; Massari F; Fiorentino M; Colecchia M; Ulbright TM; Acosta AM
Virchows Arch; 2024 Apr; 484(4):709-713. PubMed ID: 38141134
[TBL] [Abstract] [Full Text] [Related]
2. testicular cancer: new developments, molecular pathology, and current research keynote.
Lopez-Beltran A
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):204-207. PubMed ID: 37975918
[TBL] [Abstract] [Full Text] [Related]
3. Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience.
Saliyeva S; Boranbayeva R; Bulegenova M; Beloussov V
Pediatr Hematol Oncol; 2024; 41(2):121-134. PubMed ID: 37898912
[TBL] [Abstract] [Full Text] [Related]
4. [
Lee K; Kim YI; Oh JS; Seo SY; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
Sci Rep; 2023 Oct; 13(1):17619. PubMed ID: 37848723
[TBL] [Abstract] [Full Text] [Related]
5. [Extragonadal germ cell tumor: A case report and review of the literature].
Li P; Wu D; Xu XF; Fu D; Jia RP; Ge JP
Zhonghua Nan Ke Xue; 2022 Nov; 28(11):1026-1030. PubMed ID: 37846120
[TBL] [Abstract] [Full Text] [Related]
6. [A Case of testicular cancer with Solitary Iliac Bone Metastasis].
Miyata H; Abe T; Iwahara N; Kikuchi H; Chiba H; Matsumoto R; Osawa T; Tanaka H; Morita K; Mitsuhashi T; Shinohara N
Hinyokika Kiyo; 2023 Sep; 69(9):259-264. PubMed ID: 37794677
[TBL] [Abstract] [Full Text] [Related]
7. FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type.
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Di Filippo G; Franchini E; Massari F; Mollica V; Tateo V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
Histopathology; 2023 Sep; 83(3):465-476. PubMed ID: 37317674
[TBL] [Abstract] [Full Text] [Related]
8. Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-only.
Richardson NH; Althouse SK; Ashkar R; Cary C; Masterson T; Foster RS; Einhorn LH; Adra N
Clin Genitourin Cancer; 2023 Aug; 21(4):467-474. PubMed ID: 37088659
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of the M371-Test Under Real-life Conditions for diagnosis and Follow Up of testicular Germ Cell Tumors.
Pycha S; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Palermo M; Pycha A; Danuser H; Trenti E
Anticancer Res; 2023 Apr; 43(4):1649-1653. PubMed ID: 36974797
[TBL] [Abstract] [Full Text] [Related]
10. Εmerging Biomarkers in the diagnosis and Treatment of testicular Tumors.
Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
[TBL] [Abstract] [Full Text] [Related]
11. French AFU cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
[TBL] [Abstract] [Full Text] [Related]
12. [Tumor Lysis Syndrome in a Patient with Germ Cell Tumor : A Case Report].
Koterazawa S; Masui K; Hama Y; Takahashi Y; Sawada A; Akamatsu S; Kobayashi T
Hinyokika Kiyo; 2022 Jun; 68(6):201-205. PubMed ID: 35850510
[TBL] [Abstract] [Full Text] [Related]
13. Electrochemical α-fetoprotein immunosensor based on Fe
Bölükbaşi ÖS; Yola BB; Karaman C; Atar N; Yola ML
Mikrochim Acta; 2022 Jun; 189(6):242. PubMed ID: 35654985
[TBL] [Abstract] [Full Text] [Related]
14. [Biomarkers in testicular cancer.].
Mayor-de-Castro J; Aragón-Chamizo J; Caño-Velasco J; Hernández-Fernández C
Arch Esp Urol; 2022 Mar; 75(2):113-117. PubMed ID: 35332880
[TBL] [Abstract] [Full Text] [Related]
15. Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor.
Barragán-Carrillo R; Mateos-Corella S; Ortiz-Hidalgo C; Izquierdo-Echavarri E; Castillejos-Molina R; Angel M; Barragan-Arteaga I; Flaig T; Bourlon MT
Oncology (Williston Park); 2021 Dec; 35(12):816-819. PubMed ID: 35088997
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical analysis of testicular rhabdomyosarcoma].
Ye JF; Zhao L; Wang GL; Hong K; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1178-1182. PubMed ID: 34916701
[TBL] [Abstract] [Full Text] [Related]
17. Successful treatment of radiotherapy and apatinib in patient with mediastinal mixed non-seminomatous germ cell tumor: A case report.
Ren C; Zhao J; Kang L; Di Y; Qiu G; Wang Q
Medicine (Baltimore); 2021 Oct; 100(43):e27617. PubMed ID: 34713845
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic factors for patients with relapsed central nervous system nongerminomatous germ cell tumors.
Abu-Arja MH; Osorio DS; Lassaletta A; Graham RT; Coven SL; Stanek JR; Bouffet E; Finlay JL; Abdelbaki MS
Pediatr Blood Cancer; 2022 Jan; 69(1):e29365. PubMed ID: 34558189
[TBL] [Abstract] [Full Text] [Related]
19. Late relapsing germ cell tumors with elevated tumor markers.
Che Y; Lusch A; Winter C; Große Siemer R; Buddensieck C; Albers P; Hiester A
World J Urol; 2022 Feb; 40(2):363-371. PubMed ID: 34518930
[TBL] [Abstract] [Full Text] [Related]
20. Tumor markers and
Dondi F; Albano D; Bertagna F; Giubbini R
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):287-292. PubMed ID: 34425969
[TBL] [Abstract] [Full Text] [Related]
[Next]
